BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Feb 09, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Precedex dexmedetomidine hydrochloride: Phase IV data

Data from a double-blind, international Phase IV trial (2001-001) in 375 mechanically ventilated patients in the ICU showed that those who took Precedex missed the primary endpoint of time spent at targeted sedation level as measured by RASS vs. patients taking midazolam (77% vs. 75%; p=0.18). Patients receiving Precedex did have a lower incidence of delirium than those receiving midazolam (54%...

Read the full 285 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >